We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chemours (CC) Declares New Process for APA Grade Viton Production
Read MoreHide Full Article
The Chemours Company (CC - Free Report) recently announced an industry-leading sustainable process innovation to manufacture Advanced Polymer Architecture (“APA”) grade Viton fluoroelastomers, without using a fluorinated polymerization aid.
Chemours now has the potential to produce the complete Viton fluoroelastomers portfolio using a non-fluorinated surfactant. The company maintains its leadership in the fluoroelastomer process and product development with this new technology and prior innovations.
Viton APA grade fluoroelastomers facilitate products and applications essential for several markets, including transportation, advanced electronics, industrial manufacturing and oil and gas. The designers and engineers identify the high performance of Viton APA grade fluoroelastomers for their capability to be durable while retaining flexibility, strength and shape in the most extreme environments.
Chemours stated that this new process to produce APA grade Viton fluoroelastomers without fluorinated polymerization aid builds upon its legacy of product innovation and industry leadership. The company noted that it continues to look for opportunities to enable better, safer, more reliable and more sustainable solutions while meeting customer and market needs.
Shares of Chemours have gained 15.7% in the past year against a 7.7% decline of the industry.
Image Source: Zacks Investment Research
Chemours, in its last earnings call, stated that it sees adjusted EBITDA in the range of $1.475-$1.575 billion for 2022, up from $1.3-$1.425 billion expected earlier.
Free cash flow for 2022 is now forecast to be more than $550 million, up from the $500 million expected earlier.
Some other top-ranked stocks in the basic materials space are Allegheny Technologies Inc. (ATI - Free Report) , Nutrien Ltd. (NTR - Free Report) and Cabot Corporation (CBT - Free Report) .
Allegheny has a projected earnings growth rate of 869.2% for the current year. The Zacks Consensus Estimate for ATI's current-year earnings has been revised 27.3% upward in the past 60 days.
Allegheny’s earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 128.9%, on average. ATI has gained around 13.6% in a year and currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Nutrien has a projected earnings growth rate of 161.9% for the current year. The Zacks Consensus Estimate for NTR’s current-year earnings has been revised 26.9% upward in the past 60 days.
Nutrien’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, the average being 5.8%. NTR has gained 62.9% in a year. The company flaunts a Zacks Rank #1.
Cabot, currently sporting a Zacks Rank #1, has an expected earnings growth rate of 21.5% for the current year. The Zacks Consensus Estimate for CBT's earnings for the current year has been revised 5.2% upward in the past 60 days.
Cabot’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average being 16.2%. CBT has gained around 11.3% over a year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Chemours (CC) Declares New Process for APA Grade Viton Production
The Chemours Company (CC - Free Report) recently announced an industry-leading sustainable process innovation to manufacture Advanced Polymer Architecture (“APA”) grade Viton fluoroelastomers, without using a fluorinated polymerization aid.
Chemours now has the potential to produce the complete Viton fluoroelastomers portfolio using a non-fluorinated surfactant. The company maintains its leadership in the fluoroelastomer process and product development with this new technology and prior innovations.
Viton APA grade fluoroelastomers facilitate products and applications essential for several markets, including transportation, advanced electronics, industrial manufacturing and oil and gas. The designers and engineers identify the high performance of Viton APA grade fluoroelastomers for their capability to be durable while retaining flexibility, strength and shape in the most extreme environments.
Chemours stated that this new process to produce APA grade Viton fluoroelastomers without fluorinated polymerization aid builds upon its legacy of product innovation and industry leadership. The company noted that it continues to look for opportunities to enable better, safer, more reliable and more sustainable solutions while meeting customer and market needs.
Shares of Chemours have gained 15.7% in the past year against a 7.7% decline of the industry.
Image Source: Zacks Investment Research
Chemours, in its last earnings call, stated that it sees adjusted EBITDA in the range of $1.475-$1.575 billion for 2022, up from $1.3-$1.425 billion expected earlier.
Free cash flow for 2022 is now forecast to be more than $550 million, up from the $500 million expected earlier.
The Chemours Company Price and Consensus
The Chemours Company price-consensus-chart | The Chemours Company Quote
Zacks Rank & Other Key Picks
Chemours currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the basic materials space are Allegheny Technologies Inc. (ATI - Free Report) , Nutrien Ltd. (NTR - Free Report) and Cabot Corporation (CBT - Free Report) .
Allegheny has a projected earnings growth rate of 869.2% for the current year. The Zacks Consensus Estimate for ATI's current-year earnings has been revised 27.3% upward in the past 60 days.
Allegheny’s earnings beat the Zacks Consensus Estimate in each of the last four quarters. It has a trailing four-quarter earnings surprise of roughly 128.9%, on average. ATI has gained around 13.6% in a year and currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Nutrien has a projected earnings growth rate of 161.9% for the current year. The Zacks Consensus Estimate for NTR’s current-year earnings has been revised 26.9% upward in the past 60 days.
Nutrien’s earnings beat the Zacks Consensus Estimate in three of the trailing four quarters, the average being 5.8%. NTR has gained 62.9% in a year. The company flaunts a Zacks Rank #1.
Cabot, currently sporting a Zacks Rank #1, has an expected earnings growth rate of 21.5% for the current year. The Zacks Consensus Estimate for CBT's earnings for the current year has been revised 5.2% upward in the past 60 days.
Cabot’s earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, the average being 16.2%. CBT has gained around 11.3% over a year.